TITAN BIOTECH Financial Statement Analysis
|
||
The Revenues of TITAN BIOTECH have increased by 16.55% YoY .
The Earnings Per Share (EPS) of TITAN BIOTECH has increased by 0.03 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
TITAN BIOTECH Last 5 Annual Financial Results
[BOM: 524717]
Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Revenues | ₹144 Cr | ₹124 Cr | ₹14,223,723 Cr | ₹79 Cr | ₹65 Cr |
Expenses | ₹114 Cr | ₹92 Cr | ₹9,605,092 Cr | ₹66 Cr | ₹56 Cr |
Operating Profit (Excl OI) | ₹30 Cr | ₹31 Cr | ₹4,618,631 Cr | ₹13 Cr | ₹8.91 Cr |
Other Income | ₹1.94 Cr | ₹0.94 Cr | ₹78,841 Cr | ₹0.45 Cr | ₹0.69 Cr |
Interest | ₹0.75 Cr | ₹0.87 Cr | ₹172,744 Cr | ₹2.35 Cr | ₹2.34 Cr |
Depreciation | ₹2.60 Cr | ₹2.37 Cr | ₹221,731 Cr | ₹1.80 Cr | ₹1.71 Cr |
Profit Before Tax | ₹28 Cr | ₹29 Cr | ₹4,270,556 Cr | ₹10 Cr | ₹5.54 Cr |
Profit After Tax | ₹21 Cr | ₹22 Cr | ₹3,170,529 Cr | ₹7.84 Cr | ₹3.91 Cr |
Consolidated Net Profit | ₹25 Cr | ₹22 Cr | ₹3,033,521 Cr | ₹7.07 Cr | ₹3.52 Cr |
Earnings Per Share (Rs) | ₹30.07 | ₹30.06 | ₹26.24 | ₹36.71 | ₹8.55 |
PAT Margin (%) | 14.42 | 14.60 | 17.55 | 22.29 | 9.87 |
ROE(%) | 19.45 | 21.44 | 27.98 | 58.74 | 21.97 |
ROCE(%) | 25.39 | 27.40 | 33.74 | 60.80 | 21.45 |
Total Debt/Equity(x) | 0.05 | 0.06 | 0.09 | 0.21 | 0.61 |
Key Financials |
||
Market Cap | : | ₹ 626.6 Cr |
Revenue (TTM) | : | ₹ 168.9 Cr |
Net Profit(TTM) | : | ₹ 22.9 Cr |
EPS (TTM) | : | ₹ 27.6 |
P/E (TTM) | : | 27.3 |
Industry Peers & Returns | 1W | 1M | 1Y |
TITAN BIOTECH | -2.7% | -0.3% | 90.8% |
PIDILITE INDUSTRIES | -6.8% | 1.3% | 12.9% |
SOLAR INDUSTRIES INDIA | -6.9% | -1.6% | 49.2% |
SRF | -1.3% | 6.3% | -6.2% |
GUJARAT FLUOROCHEMICALS | -1.3% | 12.7% | 28.7% |
DEEPAK NITRITE | -3.5% | -0.9% | 14.2% |
TATA CHEMICALS | -5.3% | -1.6% | 2.5% |
GODREJ INDUSTRIES | 1.7% | 11.8% | 65.4% |
AARTI INDUSTRIES | -7.9% | -5.1% | -31% |
TITAN BIOTECH Revenues
[BOM: 524717]
Y-o-Y | 16.55 % |
5 Yr CAGR | 22.04 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹144 Cr | 16.55 | |
Mar2023 | ₹124 Cr | -100.00 | |
Mar2022 | ₹14,223,723 Cr | 17,905,338.91 | |
Mar2021 | ₹79 Cr | 22.39 | |
Mar2020 | ₹65 Cr | - |
TITAN BIOTECH Operating Profit
[BOM: 524717]
Y-o-Y | -5.60 % |
5 Yr CAGR | 34.93 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹30 Cr | -5.60 | |
Mar2023 | ₹31 Cr | -100.00 | |
Mar2022 | ₹4,618,631 Cr | 34,242,419.18 | |
Mar2021 | ₹13 Cr | 51.47 | |
Mar2020 | ₹8.91 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -19.00 % |
5 Yr CAGR | 10.56 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 20.5% | -19.00 | |
Mar2023 | 25.31% | -22.05 | |
Mar2022 | 32.47% | 91.22 | |
Mar2021 | 16.98% | 23.76 | |
Mar2020 | 13.72% | - |
TITAN BIOTECH Profit After Tax
[BOM: 524717]
Y-o-Y | 14.57 % |
5 Yr CAGR | 62.97 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹25 Cr | 14.57 | |
Mar2023 | ₹22 Cr | -100.00 | |
Mar2022 | ₹3,033,521 Cr | 42,931,134.93 | |
Mar2021 | ₹7.07 Cr | 100.62 | |
Mar2020 | ₹3.52 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -1.23 % |
5 Yr CAGR | 9.94 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 14.42 % | -1.23 | |
Mar2023 | 14.6 % | -16.81 | |
Mar2022 | 17.55 % | -21.27 | |
Mar2021 | 22.29 % | 125.84 | |
Mar2020 | 9.87 % | - |
TITAN BIOTECH Earnings Per Share (EPS)
[BOM: 524717]
Y-o-Y | 0.03 % |
5 Yr CAGR | 36.94 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹30 | 0.03 | |
Mar2023 | ₹30 | 14.56 | |
Mar2022 | ₹26 | -28.52 | |
Mar2021 | ₹37 | 329.36 | |
Mar2020 | ₹8.55 | - |
TITAN BIOTECH Return on Capital Employed (ROCE)
[BOM: 524717]
Y-o-Y | -7.34 % |
5 Yr CAGR | 4.31 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 25.39% | -7.34 | |
Mar2023 | 27.4% | -18.79 | |
Mar2022 | 33.74% | -44.51 | |
Mar2021 | 60.8% | 183.45 | |
Mar2020 | 21.45% | - |
TITAN BIOTECH Share Price vs Sensex
Current Share Price | : | ₹754.9 |
Current MarketCap | : | ₹ 626.6 Cr |
Updated EOD on | : | Dec 20,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TITAN BIOTECH | -2.7% |
-0.3% |
90.8% |
SENSEX | -5% |
0.6% |
9.2% |
TITAN BIOTECH related INDICES
You may also like the below Video Courses
FAQ about TITAN BIOTECH Financials
How the annual revenues of TITAN BIOTECH have changed ?
The Revenues of TITAN BIOTECH have increased by 16.55% YoY .
How the Earnings per Share (EPS) of TITAN BIOTECH have changed?
The Earnings Per Share (EPS) of TITAN BIOTECH has increased by 0.03 % YoY .
PIDILITE INDUSTRIES LTD vs SOLAR INDUSTRIES INDIA LTD vs SRF LTD
GUJARAT FLUOROCHEMICALS LTD vs DEEPAK NITRITE LTD vs